|
|
|
|
Direct Cost |
Indirect Cost |
|
261201200021I-0-26100005-1 |
Efficacy Of Metformin In The Methylnitrosourea-Induced Model Of ER |
UNIVERSITY OF ALABAMA AT BIRMINGHAM |
NCI |
|
|
$435,900 |
268200900047C-9-0-1 |
SPRINT |
UNIVERSITY OF ALABAMA AT BIRMINGHAM |
NHLBI |
|
|
$2,490,262 |
268201300025C-0-0-1 |
IGF::OT::IGF |
UNIVERSITY OF ALABAMA AT BIRMINGHAM |
NHLBI |
|
|
$1,710,693 |
268201300026C-0-0-1 |
IGF::OT::IGF RD CORONERY ARTERY RISK DEVELOPMENT IN YOUNG ADULTS (CARDIA) FIELD |
UNIVERSITY OF ALABAMA AT BIRMINGHAM |
NHLBI |
|
|
$512,216 |
272201000027I-4-27200001-1 |
Animal Models of Infectious Diseases |
UNIVERSITY OF ALABAMA AT BIRMINGHAM |
NIAID |
|
|
$4,309 |
272201000027I-4-27200001-2 |
Task A01: Mouse and Guinea Pig Models for Herpesviruses |
UNIVERSITY OF ALABAMA AT BIRMINGHAM |
NIAID |
|
|
$638,836 |
272201100016I-0-27200004-1 |
Task B14: Papillomavirus secondary Assay |
UNIVERSITY OF ALABAMA AT BIRMINGHAM |
NIAID |
|
|
$12,178 |
272201100016I-0-27200005-1 |
Task B12: Comprehensive Virology Panel |
UNIVERSITY OF ALABAMA AT BIRMINGHAM |
NIAID |
|
|
$656,876 |
272201100016I-0-27200005-2 |
Task B12: Comprehensive Virology Panel |
UNIVERSITY OF ALABAMA AT BIRMINGHAM |
NIAID |
|
|
$437,916 |
272201100016I-0-27200005-3 |
Task B12: Comprehensive Virology Panel |
UNIVERSITY OF ALABAMA AT BIRMINGHAM |
NIAID |
|
|
$193,199 |
272201100035C-1-0-1 |
Targeted Clinical Research Program to Address Selected Viral Infections |
UNIVERSITY OF ALABAMA AT BIRMINGHAM |
NIAID |
|
|
$1,025,857 |
272201100036C-1-0-1 |
Targeted Clinical Research Program to Address Selected Viral Infections |
UNIVERSITY OF ALABAMA AT BIRMINGHAM |
NIAID |
|
|
$1,436,332 |
272201100037C-1-0-1 |
Targeted Clinical Research Program to Address Selected Viral Infections |
UNIVERSITY OF ALABAMA AT BIRMINGHAM |
NIAID |
|
|
$744,300 |
272201100038C-1-0-1 |
Targeted Clinical Research Program to Address Selected Viral Infections |
UNIVERSITY OF ALABAMA AT BIRMINGHAM |
NIAID |
|
|
$403,783 |
272201100038C-1-0-2 |
Targeted Clinical Research Program to Address Selected Viral Infections |
UNIVERSITY OF ALABAMA AT BIRMINGHAM |
NIAID |
|
|
$403,784 |
272201300012I-0-27200001-1 |
SEXUALLY TRANSMITTED INFECTIONS CLINICAL TRIALS GROUP |
UNIVERSITY OF ALABAMA AT BIRMINGHAM |
NIAID |
|
|
$1,168,194 |
272201300012I-0-27200002-1 |
Sexually Transmitted Infections Clinical Trials Group |
UNIVERSITY OF ALABAMA AT BIRMINGHAM |
NIAID |
|
|
$710 |
275201300014C-0-0-1 |
ASTHMA CONTROL VARIABILITY DURING PREGNANCY |
UNIVERSITY OF ALABAMA AT BIRMINGHAM |
NICHD |
|
|
$699,719 |
N01AI40073-27-0-1 |
Sexually Transmitted Infections Clinical Trials Group |
UNIVERSITY OF ALABAMA AT BIRMINGHAM |
NIAID |
|
|
$1,072,457 |
N01AI40073-27-0-3 |
Sexually Transmitted Infections Clinical Trials Group |
UNIVERSITY OF ALABAMA AT BIRMINGHAM |
NIAID |
|
|
$938,097 |